Release of inositol phosphoglycan P-type by the human placenta following insulin stimulus: A multiple comparison between preeclampsia, intrauterine growth restriction, and gestational hypertension

References

• Higgins J R, de Swiet M. Blood-pressure measurement and classification in pregnancy. Lancet 2001; 357: 131–135
   PubMed Web of Science ®Google Scholar
• Laviola L, Perrini S, Belsanti G, Natalicchio A, Montrone C, Leonardini A, Vimercati A, Scioscia M, Selvaggi L, Giorgino R, et al. Intrauterine growth restriction in humans is associated with abnormalities in placental insulin-like growth factor signaling. Endocrinology 2005; 146: 1498–1505
   PubMed Web of Science ®Google Scholar
• Redman C W, Sargent I L. Pre-eclampsia, the placenta and the maternal systemic inflammatory response—a review. Placenta 2003; 24(Suppl A)S21–27
   PubMed Web of Science ®Google Scholar
• Jansson T, Powell T L. Human placental transport in altered fetal growth: Does the placenta function as a nutrient sensor? A review. Placenta 2006 Apr; 27 Suppl A: S91–7
   Google Scholar
• Ciampelli M, Lanzone A, Caruso A. Insulin in obstetrics: A main parameter in the management of pregnancy. Hum Reprod Update 1998; 4: 904–914
   Google Scholar
• Kaaja R, Laivuori H, Laakso M, Tikkanen M J, Ylikorkala O. Evidence of a state of increased insulin resistance in preeclampsia. Metabolism 1999; 48: 892–896
   PubMed Web of Science ®Google Scholar
• Caruso A, Ferrazzani S, De Carolis S, Lucchese A, Lanzone A, De Santis L, Paradisi G. Gestational hypertension but not pre-eclampsia is associated with insulin resistance syndrome characteristics. Hum Reprod 1999; 14: 219–223
   PubMed Web of Science ®Google Scholar
• Muller G, Wied S, Piossek C, Bauer A, Bauer J, Frick W. Convergence and divergence of the signaling pathways for insulin and phosphoinositolglycans. Mol Med 1998; 4: 299–323
   PubMed Web of Science ®Google Scholar
• Varela-Nieto I, Leon Y, Caro H N. Cell signalling by inositol phosphoglycans from different species. Comp Biochem Physiol B Biochem Mol Biol 1996; 115: 223–241
   PubMedGoogle Scholar
• Kunjara S, Greenbaum A L, Wang D Y, Caro H N, McLean P, Redman C W, Rademacher T W. Inositol phosphoglycans and signal transduction systems in pregnancy in preeclampsia and diabetes: Evidence for a significant regulatory role in preeclampsia at placental and systemic levels. Mol Genet Metab 2000; 69: 144–158
   PubMed Web of Science ®Google Scholar
• Villar J, Carroli G, Wojdyla D, Abalos E, Giordano D, Ba'aqeel H, Farnot U, Bergsjo P, Bakketeig L, Lumbiganon P, et al. Preeclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions. Am J Obstet Gynecol 2006; 194: 921–931
   PubMed Web of Science ®Google Scholar
• Scioscia M, Gumaa K, Kunjara S, Paine M A, Selvaggi L E, Rodeck C H, Rademacher T W. Insulin resistance in human preeclamptic placenta is mediated by serine phosphorylation of insulin receptor substrate-1 and -2. J Clin Endocrinol Metab 2006; 91: 709–717
   PubMedGoogle Scholar
• Resnik R. Intrauterine growth restriction. Obstet Gynecol 2002; 99: 490–496
   PubMed Web of Science ®Google Scholar
• Suzuki S, Toyota T, Suzuki H, Goto Y. Partial purification from human mononuclear cells and placental plasma membranes of an insulin mediator which stimulates pyruvate dehydrogenase and suppresses glucose-6-phosphatase. Arch Biochem Biophys 1984; 235: 418–426
   Google Scholar
• Lilley K, Zhang C, Villar-Palasi C, Larner J, Huang L. Insulin mediator stimulation of pyruvate dehydrogenase phosphatases. Arch Biochem Biophys 1992; 296: 170–174
   PubMed Web of Science ®Google Scholar
• Paine M A, Scioscia M, Gumaa K A, Rodeck C H, Rademacher T W. P-type inositol phosphoglycans in serum and amniotic fluid in active pre-eclampsia. J Reprod Immunol 2006; 69: 165–179
   PubMed Web of Science ®Google Scholar
• Williams P J, Gumaa K, Scioscia M, Redman C W, Rademacher T W. Inositol phosphoglycan P-type in preeclampsia: A novel marker. Hypertension 2007; 49: 84–89
   PubMed Web of Science ®Google Scholar
• Rademacher T W, Gumaa K, Scioscia M. Preeclampsia, insulin signalling and immunological dysfunction: A fetal, maternal or placental disorder. J Reprod Immunol 2007; 76: 78–94
   Google Scholar
• Scioscia M, Gumaa K, Whitten M, Selvaggi L E, Rodeck C H, Rademacher T W. Inositol phosphoglycan P-type in healthy and preeclamptic pregnancies. J Reprod Immunol 2007; 76: 85–90
   Google Scholar
• Saudan P, Brown M A, Buddle M L, Jones M. Does gestational hypertension become pre-eclampsia. Br J Obstet Gynaecol 1998; 105: 1177–1184
   PubMedGoogle Scholar
• Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005; 365: 785–799
   PubMed Web of Science ®Google Scholar
• Piper J M, Langer O, Xenakis E M, McFarland M, Elliott B D, Berkus M D. Perinatal outcome in growth-restricted fetuses: Do hypertensive and normotensive pregnancies differ. Obstet Gynecol 1996; 88: 194–199
   PubMed Web of Science ®Google Scholar
• Cywinski J. The essentials in pressure monitoring. Martinus Nijhoff Publishers, BostonUSA 1980; 23–24
   Google Scholar